244 related articles for article (PubMed ID: 25552639)
1. Nigral dopamine loss induces a global upregulation of presynaptic dopamine D1 receptor facilitation of the striatonigral GABAergic output.
Ding S; Li L; Zhou FM
J Neurophysiol; 2015 Mar; 113(6):1697-711. PubMed ID: 25552639
[TBL] [Abstract][Full Text] [Related]
2. Dopaminergic treatment weakens medium spiny neuron collateral inhibition in the parkinsonian striatum.
Wei W; Ding S; Zhou FM
J Neurophysiol; 2017 Mar; 117(3):987-999. PubMed ID: 27927785
[TBL] [Abstract][Full Text] [Related]
3. Hyperactive Response of Direct Pathway Striatal Projection Neurons to L-dopa and D1 Agonism in Freely Moving Parkinsonian Mice.
Sagot B; Li L; Zhou FM
Front Neural Circuits; 2018; 12():57. PubMed ID: 30104963
[TBL] [Abstract][Full Text] [Related]
4. Supersensitive presynaptic dopamine D2 receptor inhibition of the striatopallidal projection in nigrostriatal dopamine-deficient mice.
Wei W; Li L; Yu G; Ding S; Li C; Zhou FM
J Neurophysiol; 2013 Nov; 110(9):2203-16. PubMed ID: 23945778
[TBL] [Abstract][Full Text] [Related]
5. Striatal But Not Extrastriatal Dopamine Receptors Are Critical to Dopaminergic Motor Stimulation.
Wang Y; Zhou FM
Front Pharmacol; 2017; 8():935. PubMed ID: 29311936
[TBL] [Abstract][Full Text] [Related]
6. Phosphodiesterase 10A controls D1-mediated facilitation of GABA release from striato-nigral projections under normal and dopamine-depleted conditions.
Mango D; Bonito-Oliva A; Ledonne A; Nisticò R; Castelli V; Giorgi M; Sancesario G; Fisone G; Berretta N; Mercuri NB
Neuropharmacology; 2014 Jan; 76 Pt A():127-36. PubMed ID: 23973317
[TBL] [Abstract][Full Text] [Related]
7. High-dose methamphetamine acutely activates the striatonigral pathway to increase striatal glutamate and mediate long-term dopamine toxicity.
Mark KA; Soghomonian JJ; Yamamoto BK
J Neurosci; 2004 Dec; 24(50):11449-56. PubMed ID: 15601951
[TBL] [Abstract][Full Text] [Related]
8. The striatonigral dynorphin pathway of the rat studied with in vivo microdialysis--II. Effects of dopamine D1 and D2 receptor agonists.
You ZB; Herrera-Marschitz M; Nylander I; Goiny M; O'Connor WT; Ungerstedt U; Terenius L
Neuroscience; 1994 Nov; 63(2):427-34. PubMed ID: 7891856
[TBL] [Abstract][Full Text] [Related]
9. 5-HT1B receptors mediate dopaminergic inhibition of vesicular fusion and GABA release from striatonigral synapses.
Molinari M; Lieberman OJ; Sulzer D; Santini E; Borgkvist A
bioRxiv; 2024 Mar; ():. PubMed ID: 38559006
[TBL] [Abstract][Full Text] [Related]
10. Serotonin hyperinnervation and upregulated 5-HT2A receptor expression and motor-stimulating function in nigrostriatal dopamine-deficient Pitx3 mutant mice.
Li L; Qiu G; Ding S; Zhou FM
Brain Res; 2013 Jan; 1491():236-50. PubMed ID: 23159831
[TBL] [Abstract][Full Text] [Related]
11. Functional neuroanatomy of the nigrostriatal and striatonigral pathways as studied with dual probe microdialysis in the awake rat--II. Evidence for striatal N-methyl-D-aspartate receptor regulation of striatonigral GABAergic transmission and motor function.
Morari M; O'Connor WT; Ungerstedt U; Bianchi C; Fuxe K
Neuroscience; 1996 May; 72(1):89-97. PubMed ID: 8730708
[TBL] [Abstract][Full Text] [Related]
12. Adenosine A1 receptor stimulation reduces D1 receptor-mediated GABAergic transmission from striato-nigral terminals and attenuates l-DOPA-induced dyskinesia in dopamine-denervated mice.
Mango D; Bonito-Oliva A; Ledonne A; Cappellacci L; Petrelli R; Nisticò R; Berretta N; Fisone G; Mercuri NB
Exp Neurol; 2014 Nov; 261():733-43. PubMed ID: 25173217
[TBL] [Abstract][Full Text] [Related]
13. Adenosine A1 receptors control dopamine D1-dependent [(3)H]GABA release in slices of substantia nigra pars reticulata and motor behavior in the rat.
Florán B; Barajas C; Florán L; Erlij D; Aceves J
Neuroscience; 2002; 115(3):743-51. PubMed ID: 12435413
[TBL] [Abstract][Full Text] [Related]
14. Robust presynaptic serotonin 5-HT(1B) receptor inhibition of the striatonigral output and its sensitization by chronic fluoxetine treatment.
Ding S; Li L; Zhou FM
J Neurophysiol; 2015 May; 113(9):3397-409. PubMed ID: 25787955
[TBL] [Abstract][Full Text] [Related]
15. Interactions between dopamine D1 receptors and gamma-aminobutyric acid mechanisms in substantia nigra pars reticulata of the rat: neurochemical and behavioral studies.
Trevitt T; Carlson B; Correa M; Keene A; Morales M; Salamone JD
Psychopharmacology (Berl); 2002 Jan; 159(3):229-37. PubMed ID: 11862355
[TBL] [Abstract][Full Text] [Related]
16. D1 agonist-induced excitation of substantia nigra pars reticulata neurons: mediation by D1 receptors on striatonigral terminals via a pertussis toxin-sensitive coupling pathway.
Martin LP; Waszczak BL
J Neurosci; 1994 Jul; 14(7):4494-506. PubMed ID: 7913124
[TBL] [Abstract][Full Text] [Related]
17. G(olf) and Gs in rat basal ganglia: possible involvement of G(olf) in the coupling of dopamine D1 receptor with adenylyl cyclase.
Hervé D; Lévi-Strauss M; Marey-Semper I; Verney C; Tassin JP; Glowinski J; Girault JA
J Neurosci; 1993 May; 13(5):2237-48. PubMed ID: 8478697
[TBL] [Abstract][Full Text] [Related]
18. Cannabinoids inhibit striatonigral GABAergic neurotransmission in the mouse.
Wallmichrath I; Szabo B
Neuroscience; 2002; 113(3):671-82. PubMed ID: 12150787
[TBL] [Abstract][Full Text] [Related]
19. In vivo evidence for a differential contribution of striatal and nigral D1 and D2 receptors to L-DOPA induced dyskinesia and the accompanying surge of nigral amino acid levels.
Mela F; Marti M; Bido S; Cenci MA; Morari M
Neurobiol Dis; 2012 Jan; 45(1):573-82. PubMed ID: 22001605
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of Nigrostriatal Dopamine Release by Striatal GABA
Lopes EF; Roberts BM; Siddorn RE; Clements MA; Cragg SJ
J Neurosci; 2019 Feb; 39(6):1058-1065. PubMed ID: 30541909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
